Explanation
Linagtiptin
Thedruahasbeenextensively studiedin patientswithrenauimpairment.andnodoseadjiustmentisrequired.t
is80%excreted inthefaeces.which accounts forthelackof needfordose adjustment inrenat impairment.
Withreqard
weiaht.Dpp iv(DipeptidvtpeptidaseIM) inhibitorsikelinaqtiptin also havesignificant
advantaqes whencompared withpioglitazoneandsulfonylureas becausethey donot increasetheriskfo
hypoglycaemiaor weight gain.
@1MINENDOCRINE
